Want to join the conversation?
Oppenheimer analyst Brian Bittner questions $TXRH whether it it is looking to accelerate capital returns. CFO Scott Colosi says that the company feels comfortable having some cash in the bank and not a lot of debt. $TXRH is committed to its dividend payment & raising the dividend at a healthy rate each year, and so has no problem buying back stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?